[{"address1": "101 Lindenwood Drive", "address2": "Suite 225", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "484 875 3192", "website": "https://www.annovisbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 2/3 to treat alzheimer's disease, as well as in phase 3 to treat parkinson's disease; and is in phase 2 clinical trial to treat lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial to treat later stages of alzheimer's disease and dementia. The company was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Maria L. Maccecchini Ph.D.", "age": 73, "title": "Founder, CEO, President, Interim Principal Financial Officer & Executive Director", "yearBorn": 1951, "fiscalYear": 2024, "totalPay": 748600, "exercisedValue": 0, "unexercisedValue": 809000}, {"maxAge": 1, "name": "Mr. Mark K. White", "age": 68, "title": "Chief Business Officer & Director", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cheng  Fang Ph.D.", "title": "Senior Vice President of Research & Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eve M. Damiano M.S., RAC", "title": "Senior Vice President of Regulatory Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melissa  Gaines", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Blake  Jensen", "title": "Head of Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hilda  Maibach", "title": "Senior Vice President of Statistics", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.58, "open": 1.58, "dayLow": 1.555, "dayHigh": 1.68, "regularMarketPreviousClose": 1.58, "regularMarketOpen": 1.58, "regularMarketDayLow": 1.555, "regularMarketDayHigh": 1.68, "payoutRatio": 0.0, "beta": 1.452, "forwardPE": -0.8895581, "volume": 166559, "regularMarketVolume": 166559, "averageVolume": 407350, "averageVolume10days": 310010, "averageDailyVolume10Day": 310010, "bid": 1.61, "ask": 1.62, "bidSize": 14, "askSize": 13, "marketCap": 31374732, "fiftyTwoWeekLow": 1.11, "fiftyTwoWeekHigh": 17.88, "fiftyDayAverage": 1.574, "twoHundredDayAverage": 5.6095, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 20236328, "profitMargins": 0.0, "floatShares": 15671217, "sharesOutstanding": 19486200, "sharesShort": 1744449, "sharesShortPriorMonth": 1879232, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.089499995, "heldPercentInsiders": 0.14446001, "heldPercentInstitutions": 0.13402, "shortRatio": 6.93, "shortPercentOfFloat": 0.1046, "impliedSharesOutstanding": 19486200, "bookValue": 0.658, "priceToBook": 2.4469604, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -24590376, "trailingEps": -2.31, "forwardEps": -1.81, "52WeekChange": -0.7379768, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 1.6101, "targetHighPrice": 72.0, "targetLowPrice": 8.0, "targetMeanPrice": 31.2, "targetMedianPrice": 26.0, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 10551916, "totalCashPerShare": 0.542, "totalDebt": 0, "quickRatio": 2.719, "currentRatio": 3.588, "returnOnAssets": -1.38265, "returnOnEquity": -31.59092, "freeCashflow": -12165856, "operatingCashflow": -21894604, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ANVS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 1.9050633, "regularMarketPrice": 1.6101, "marketState": "REGULAR", "exchange": "NYQ", "messageBoardId": "finmb_622711087", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "regularMarketTime": 1746723396, "cryptoTradeable": false, "shortName": "Annovis Bio, Inc.", "longName": "Annovis Bio, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1580308200000, "regularMarketChange": 0.0301, "regularMarketDayRange": "1.555 - 1.68", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 407350, "fiftyTwoWeekLowChange": 0.5001, "fiftyTwoWeekLowChangePercent": 0.45054054, "fiftyTwoWeekRange": "1.11 - 17.88", "fiftyTwoWeekHighChange": -16.2699, "fiftyTwoWeekHighChangePercent": -0.90994966, "fiftyTwoWeekChangePercent": -73.797676, "earningsTimestamp": 1742591130, "earningsTimestampStart": 1746820800, "earningsTimestampEnd": 1747684800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.31, "epsForward": -1.81, "epsCurrentYear": -0.78, "priceEpsCurrentYear": -2.064231, "fiftyDayAverageChange": 0.03610003, "fiftyDayAverageChangePercent": 0.022935215, "twoHundredDayAverageChange": -3.9994, "twoHundredDayAverageChangePercent": -0.71296906, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "displayName": "Annovis Bio", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]